Dosage reduction of low weight heparin in patients with renal dysfunction: Effects on anti-Xa levels and clinical outcomes-Reference-Cited by-同舟云学术

Dosage reduction of low weight heparin in patients with renal dysfunction: Effects on anti-Xa levels and clinical outcomes

Published:2020-10-01 Issue:10 Volume:15 Page:e0239222
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Hornung Paul,Khairoun Meriem,Dekker Friedo W.,Kaasjager Karin A. H.,Huisman Albert^ORCID,Jakulj Lily,Bos Willem Jan W.,Rosendaal Frits R.,Verhaar Marianne C.,Ocak Gurbey^ORCID

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference35 articles.

1. Low-molecular-weight heparins;JI Weitz;N Engl J Med,1997

2. Dose adjusted heparin treatment of deep venous thrombosis: a comparison of unfractionated and low molecular weight heparin;GF Handeland;Eur J Clin Pharmacol,1990

3. Ex-vivo and in-vitro evidence that low molecular weight heparins exhibit less binding to plasma proteins than unfractionated heparin;E Young;Thromb Haemost,1994

4. Comparison of the non-specific binding of unfractionated heparin and low molecular weight heparin (Enoxaparin) to plasma proteins;E Young;Thromb Haemost,1993

5. Effects of an enzymatically depolymerized heparin as compared with conventional heparin in healthy volunteers;T Matzsch;Thromb Haemost,1987

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Venous thromboembolism in pregnancy and postpartum: an illustrated review;Research and Practice in Thrombosis and Haemostasis;2024-05

2. Smaller nadroparin dose reductions required for patients with renal impairment: A multicenter cohort study;Thrombosis Research;2024-04

3. The effect of renal impairment and obesity on anti-Xa peak and trough levels in patients receiving therapeutic doses of nadroparin: a comparison with control patients;European Journal of Clinical Pharmacology;2023-09-14

4. Critical appraisal of evidence for anti-Xa monitoring and dosing of low-molecular-weight heparin in renal insufficiency;Expert Review of Clinical Pharmacology;2022-10-03

5. Therapeutically dosed low molecular weight heparins in renal impairment: a nationwide survey;European Journal of Clinical Pharmacology;2022-06-17